<DOC>
	<DOCNO>NCT02445274</DOCNO>
	<brief_summary>In study , investigator introduce new `` capsule-reserved '' cataract surgical procedure anterior lens capsule reserve attached onto posterior lens capsule purpose prevent posterior capsule opacification ( PCO ) . A prospective randomized control study report compare new `` capsule-reserved '' surgical procedure conventional one effectiveness prevent posterior capsule opacification age-related cataract patient .</brief_summary>
	<brief_title>Two Different Cataract Surgical Procedures Prevent Posterior Capsule Opacification</brief_title>
	<detailed_description>A prospective , randomize control study 240 eligible patient enrol . Two eye patient assign randomly two group respectively : Group I ; anterior lens capsule conventionally reserve continuous curvilinear capsulorhexis , Group II , anterior lens capsule innovatively reserve attach onto posterior lens capsule . This novel adjust surgical procedure , feature use reserve anterior lens capsule protect peri-capsule microenvironment prevent PCO , conceptual different traditional cataract surgical procedure . Clinical examination include posterior capsule opacification grade score , central posterior capsule thickness , central posterior capsule density , best correct visual acuity , contrast sensitivity carry preoperatively postoperative visit .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Capsule Opacification</mesh_term>
	<criteria>1 . Aged 50 year 2 . Both eye diagnose agerelated cataract 3 . Both eye plan undergo `` Phacoemulsification IOL implantation '' surgery 1 month 4 . Biocular BCVA improvement post surgery feasible judged ophthalmologist . 1 . Other ocular disease 2 . ACD &lt; 3CT 3 . Combined cataract surgery ( trabeculoplasty , keratoplasty ) 4 . Lens pseudoexfoliation syndrome combine glaucoma zonular abnormality 5 . Previous intraocular surgery trauma ( laser include ) 6 . Uveitis 7 . Recent ocular infection 8 . Proliferative diabetic retinopathy 9 . Diabetes mellitus 10 . Congenital ocular abnormality ( aniridia , congenital cataract ) 11 . Atrophy iris 12 . Participants previous clinical trial 30 day surgery 13 . Using prostanoid eye drop 14 . Uncontrolled systematic disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>